Independent ethics committee curbs seen hurting Indian studies
This article was originally published in SRA
Executive Summary
Following on from the Supreme Court of India issuing strict time-bound instructions to the government concerning the regulatory regime for clinical trials, a new notice restricting the scope of activities of independent ethics committees (ECs) is expected to have a crushing impact on investigator-led and post-marketing studies in the country1.